Interleukin-1 and Transforming Growth Factor-ß 1 as Crucial Factors in Osteoarthritic Cartilage Metabolism

REFERENCES

• Kuettner K.E., Cole A.A. Cartilage degeneration in different human joints. Osteoarthr. Cart. 2005; 13: 93–103
   PubMed Web of Science ®Google Scholar
• Felson D.T., Gale D.R., Elon G.M., Niu J., Hunter D.J., Goggins J., Lavalley M.P. Osteophytes and progression of knee osteoarthritis. Rheumatology (Oxford) 2005; 44: 100–104
   PubMed Web of Science ®Google Scholar
• Brighton C.T., Heppenstall R.B. Oxygen tension in zones of the epiphyseal plate, the metaphysis and diaphysis: an in vitro and in vivo study in rats and rabbits. J. Bone Joint Surg. Am. 1971; 53: 719–728
   PubMed Web of Science ®Google Scholar
• Rajpurohit R., Koch C.J., Tao Z., Teixerira C.M., Shapiro I.M. Adaptation of chondrocytes to low oxygen tension: relationship between hypoxia and cellular metabolism. J. Cell. Physiol. 1996; 168: 424–432
   PubMed Web of Science ®Google Scholar
• Pritzker K.P., Gay S., Jimenez S.A., Ostergaard K., Pelletier J.P., Revell P.A., Salter D., Van Den Berg W.B. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr. Cart. 2006; 14: 13–29
   PubMed Web of Science ®Google Scholar
• Dingle J.T. Catabolin—a cartilage catabolic factor from synovium. Clin. Orthop. Relat. Res. 1981; 156: 219–231
   PubMed Web of Science ®Google Scholar
• Pujol J.P., Loyau G. Interleukin-1 and osteoarthritis. Life Sci. 1987; 41: 1187–1198
   PubMed Web of Science ®Google Scholar
• Wood D.D., Ihrie E.J., Dinarello C.A., Cohen P.L. Isolation of an interleukin-1 like factor from human joint effusions. Arthr. Rheum. 1983; 26: 975–983
   PubMed Web of Science ®Google Scholar
• Pelletier J.P., Martel-Pelletier J. Evidence for the involvement of interleukin-1 in human osteoarthritic cartilage degradation: protective effect of NSAID. J. Rheumatol. 1989; 16: 19–27
   PubMed Web of Science ®Google Scholar
• Farahat M.N., Yanni G., Poston R., Panayi G.S. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and ostoarthritis. Ann. Rheum. Dis. 1993; 52: 870–875
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J., Zafarullah M., Kodama S., Pelletier J.P. In vitro effects of interleukin-1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage. J. Rheumatol. 1991; 18: 80–84
   Web of Science ®Google Scholar
• Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthr. Cart. 2004; 12(Suppl A)S31–S33
   PubMedGoogle Scholar
• Pasternak R.D., Hubbs S.J., Caccese RG, Marks R.L, Conaty J.M., DiPasquale G. Interleukin-1 stimulates the secretion of proteoglycan- and collagen-degrading proteases by rabbit articular chondrocytes. Clin. Immunol. Immunopathol. 1986; 41: 351–367
   PubMedGoogle Scholar
• Bocquet J., Daireaux M., Langris M., Jouis V., Pujol J.P., Béliard R., Loyau G. Effect of a interleukin-1 like factor (mononuclear cell factor) on proteoglycan synthesis in cultured human articular chondrocytes. Biochem. Biophys. Res. Commun. 1986; 134: 539–549
   PubMed Web of Science ®Google Scholar
• Goldring M. B., Birkead J., Kimura T., Krane S. M. Interleukin-1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J. Clin. Invest. 1988; 82: 2026–2037
   PubMed Web of Science ®Google Scholar
• Lefebvre V., Peeters-Joris C., Vaes G. Modulation by interleukin-1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim. Biophys. Acta 1990; 366: 1052–378
   Google Scholar
• Pelletier J.P., Martel-Pelletier, Howell D.S. Etiopathogenesis of osteoarthritis. Arthritis and Allied Conditions, A Textbook of Rheumatology, W.J. Koopman. (Williams & Wilkins), Baltimore 1997; 1969–1984
   Google Scholar
• Guerne P.A., Zuraw B.L., Vaughan J.H., Carson D.A., Lotz M. Synovium as a source of interleukin-6 in vitro. Contribution to local and systemic manifestations of arthritis. J. Clin. Invest. 1989; 83: 585–592
   PubMed Web of Science ®Google Scholar
• Legendre F., Dudhia J., Pujol J.P., Bogdanowicz P. JAK/STAT but not ERK1/ERK2 pathway mediates IL-6/sIL-6R down-regulation of type II collagen, aggrecan core and link protein transcription in articular chondrocytes. J. Biol. Chem. 2003; 278: 2903–2912
   PubMed Web of Science ®Google Scholar
• Legendre F., Pujol J.P., Boumediene K., Bogdanowicz P. Role of IL-6/IL-6R induced STATs and MAPK/ERKs in up-regulation of MMPs (-1, -3, -13) and ADAMTS (-4, -5/11) gene expression in articular chondrocytes. J. Rhumatol. 2005; 32: 1307–1316
   PubMed Web of Science ®Google Scholar
• Van Den Berg W.B., van der Kraan P.M., van Beuningen H.M. Role of growth factors and cartilage repair. Osteoarthritis—Clinical and Experimental Aspects, J.Y. Reginster, J.P. Pelletier, J. Martel-Pelletier, Y. Henrotin. Springer-Verlag, Berlin Heidelberg, New York 1999; 188–209
   Google Scholar
• Galéra P., Rédini F., Vivien D., Bonaventure J., Penfornis H., Loyau G., Pujol J.P. Effect of transforming growth factor-ß1 (TGF-β1) on matrix synthesis by monolayer cultures of rabbit articular chondrocytes during the dedifferentiation process. Exp. Cell. Res. 1992; 200: 379–392
   PubMed Web of Science ®Google Scholar
• Rédini F., Galéra P., Mauviel A., Loyau G., Pujol J.P. Transforming growth factor-ß stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes. FEBS Lett. 1988; 234: 172–176
   PubMed Web of Science ®Google Scholar
• Rédini F., Daireaux M., Mauviel A., Galéra P., Loyau G., Pujol J.P. Characterization of proteoglycans synthesized by rabbit articular chondrocytes in response to transforming growth factor-ß. Biochim. Biophys. Acta 1991; 196: 1093–206
   Google Scholar
• Rédini F., Mauviel A., Pronost S., Loyau G., Pujol J.P. Transforming growth factor ß exerts opposite effects from Interleukin-1ß (IL-1ß) on cultured rabbit articular chondrocytes through reduction of IL-1 receptor expression. Arthri. Rheum. 1993; 36: 44–50
   PubMed Web of Science ®Google Scholar
• Van Der Kraan P.M., Glansbeek H.L., Vitters E.L., van den Berg W.B. Early elevation of transforming growth factor-ß, decorin and biglycan mRNA levels during cartilage matrix restoration after mild proteoglycan depletion. J. Rheumatol. 1997; 24: 543–549
   PubMed Web of Science ®Google Scholar
• Boumediene K., Conrozier T., Mathieu P., Richard M., Marcelli C., Vignon E., Pujol J.P. Decrease of cartilage transforming growth factor-ß receptor II expression in the rabbit experimental osteoarthritis—potential role in cartilage breakdown. Osteoarthr. Cart 1998; 6: 146–149
   PubMed Web of Science ®Google Scholar
• Zhou G., Lefebvre V., Zhang Z. P., Eberspaecher H., de Crombrugghe B. Three high mobility group-like sequences within a 48-base pair enhancer of the COL2A1 gene are required for cartilage-specific expression in vivo. J. Biol. Chem. 1998; 273: 14989–14997
   PubMed Web of Science ®Google Scholar
• Lefebvre V., Li P., de Crombrugghe B. A new long form of SOX5 (L-SOX5), SOX6 and SOX9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 1998; 17: 5718–5733
   PubMed Web of Science ®Google Scholar
• Ghayor C., Herrouin J.-F., Chadjichristos C., Ala-Kokko L., Takigawa M., Pujol J.P., Galéra P. Regulation of human COL2A1 gene expression in chondrocytes. Identification of C-Krox responsive elements and modulation by phenotype alteration. J. Biol. Chem. 2000; 275: 27421–27438
   PubMed Web of Science ®Google Scholar
• Ghayor C., Chadjichristos C., Herrouin J.-F., Ala-Kokko L., Suske G., Pujol J.P., Galéra P. Sp3 represses the Sp1-mediated transactivation of human COL2A1 gene in primary and dedifferentiated chondrocytes. J. Biol. Chem. 2001; 276: 36881–36895
   PubMed Web of Science ®Google Scholar
• Chadjichristos C., Ghayor C., Herrouin J.-F., Ala-Kokko L., Suske G., Pujol J.P., Galéra P. Sp3 represses the Sp1-mediated transactivation of the human COL2A1 gene in primary and de-differentiated chondrocytes. J. Biol. Chem. 2002; 276: 36881–36895
   Web of Science ®Google Scholar
• Goldring M. B., Suen L.-F., Yamin R., Lai W.F. Regulation of collagen gene expression by prostaglandins and interleukin-1beta in cultured chondrocytes and fibroblast. Am. J. Therapeutics 1996; 3: 9–16
   PubMedGoogle Scholar
• Goldring M. B., Birkhead J. R., Suen L.F., Yamin R., Mizuno S., Glowaski J., Arbiser J. L., Appeley J. F. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J. Clin. Invest. 1994; 94: 2307–2316
   PubMed Web of Science ®Google Scholar
• Murakami S., Lefebvre V., de Crombrugghe B. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. J. Biol. Chem. 2000; 275: 3687–3692
   PubMed Web of Science ®Google Scholar
• Tan L., Peng H., Osaki M., Choy B. K., Auron P. E., Sandell L. J., Goldring M. B. Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. J. Biol. Chem. 2003; 278: 17688–17700
   PubMed Web of Science ®Google Scholar
• Chadjichristos C., Ghayor C., Kypriotou M., Martin G., Renard E., Ala-Kokko L., Suske G., De Crombrugghe B., Pujol J.-P., Galéra P. Sp1 and Sp3 transcription factors mediate IL-1ß down-regulation of human type II collagen gene expression in articular chondrocytes. J. Biol. Chem. 2003; 278: 39762–39772
   PubMed Web of Science ®Google Scholar
• Serra R., Johnson M., Filvaroff E.H., Laborde J., Sheehan D.M., Derynck R., Moses H.L. Expression of a truncated kinase defective TGF-β type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J. Cell Biol. 1997; 139: 541–552
   PubMed Web of Science ®Google Scholar
• van Beuningen H.M., van der Kraan P.M., Arntz O.J., van den Berg W.B. In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-ß 1:age-related differences. Ann. Rheum. Dis. 1994; 53: 593–600
   PubMed Web of Science ®Google Scholar
• Andriamanalijaona R., Felisaz N., Kim S.J., King-Jones K., Lehmann M., Pujol J.P., Boumediene K. Mediation of interleukin-1ß-induced transforming growth factor-ß1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: possible cooperation with activator protein 1. Arthr. Rheum. 2003; 48: 1570–1581
   Web of Science ®Google Scholar
• Baugé C., Legendre F., Leclercq S., Elissalde J.M., Pujol J.P., Galéra P., Boumediene K. Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes. Arthr. Rheum. 2007; 56: 3020–3032
   PubMed Web of Science ®Google Scholar
• Bae H.W., Geiser A.G., Kim D.H., Chung M.T., et al. Characterization of the promoter region of the human transforming growth factor-ß type II receptor gene. J. Biol. Chem. 1995; 270: 29460–29468
   PubMed Web of Science ®Google Scholar
• Choi S.G., Yi Y.S., Kim Y.S., Kato J., Chang J., Chung H.W., Hahm K.B., Yang H.K., Rhee H.H., Bang Y.J., Kim S.J. A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-ß type II receptor. J. Biol. Chem. 1998; 273: 110–117
   PubMed Web of Science ®Google Scholar
• Kelly D., Kim S.J., Rizzino A. Transcripttional activation of the type II transforming growth factor-ß receptor gene upon differentiation of embryonal carcinoma cells. J. Biol. Chem. 1998; 273: 21115–21124
   PubMed Web of Science ®Google Scholar
• Kopp J.L., Wilder P.J., Desler M., Kim J.H., Hou J., Nowling T., Rizzino A. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1 on the promoter of the type II transforming growth factor-ß receptor gene. J. Biol. Chem. 2004; 279: 19407–19420
   PubMed Web of Science ®Google Scholar
• Lee Park S.H. S.R., Kim B.C., Cho E.A., Patel S.P., Kang H.B., Sausville E.A., Nakanishi O., Trepel J.B., Lee B.I., Kim S.J. Transcriptional regulation of the transforming growth factor-ß type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells. J. Biol. Chem. 2002; 277: 5168–5174
   PubMed Web of Science ®Google Scholar
• Lee B.I., Park S.H., Kim J.W., Sausville E.A., Kim H.T., et al. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor-ß type II receptor expression in human breast cancer cells. Cancer Res. 2001; 61: 931–934
   PubMed Web of Science ®Google Scholar
• Park S.H., Kim Y.S., Park B.K., Hougaard S., Kim S.J. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen henein human gastric cancer cell lines: implication for the loss of TGF-β type II receptor expression. Oncogene 2001; 20: 1235–1245
   PubMed Web of Science ®Google Scholar
• Baugé C., Attia J., Leclercq S., Pujol J.P., Galéra P., Boumediene K. IL-1ß upregulates Smad7 via NF-kB activation in human chondrocytes. Arthritis Rheum. 2008; 58: 221–226
   PubMed Web of Science ®Google Scholar
• Baugé C., Beauchef G., Leclercq S., Kim S.J., Pujol J.P., Galéra P. NF-kB mediates IL-1B-induced down-regulation of T. ßRII through the modulation of Sp3 expression. J. Cell. Mol. Med. 2008, 2007 Dec. 5 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Monslow J., Williams J.D., Fraser D.J., Michael D.R., Foka P., Kift-Morgan A.P., Luo D.D., Fielding C.A., Craig K.J., Topley N., Jones S.A., Ramji D.P., Bowen T. Sp1 and Sp3 mediate constitutive transcription of the human hyaluronan synthase 2 gene. J. Biol. Chem. 2006; 281: 18043–18050
   PubMed Web of Science ®Google Scholar
• Hahm K.B., Cho K., Lee C., Im Y.H., Chang J., Choi S.G., Sorensen P.H., Thiele C.J., Kim S.J. Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat. Genet. 1999; 23: 222–227
   PubMed Web of Science ®Google Scholar
• Markowitz S., Wang J., Myeroff L., Parsons R., Sun L., Lutterbaugh J., Fan R.S., Zborowska E., Kinzler K.W., Vogelstein B., et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995; 268: 1336–1338
   PubMed Web of Science ®Google Scholar
• Park K., Kim S.J., Bang Y.J., Park J.G., Kim N.K., Roberts A.B., Sporn M.B. Genetic changes in the transforming growth factor-ß (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA 1994; 91: 8772–8776
   PubMed Web of Science ®Google Scholar